Back to top

SNDX Maintains Rating by HC Wainwright & Co. -- Price Target Lowered to $38

SNDX Maintains Rating by HC Wainwright & Co. -- Price Target Lowered to $38

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Syndax Pharmaceuticals, Inc. (SNDX)